Plasma Clusterin as a Potential Link Between Diabetes and Alzheimer Disease
- PMID: 32561922
- DOI: 10.1210/clinem/dgaa378
Plasma Clusterin as a Potential Link Between Diabetes and Alzheimer Disease
Abstract
Objective: Plasma clusterin, a promising biomarker of Alzheimer disease (AD), has been associated with diabetes mellitus (DM). However, clusterin has not been investigated considering a relationship with both DM and AD. In this study, we aimed to investigate the individual and interactive relationships of plasma clusterin levels with both diseases.
Design: Cross-sectional observation study.
Methods: We classified participants by the severity of cognitive (normal cognition, mild cognitive impairment [MCI], and AD) and metabolic (healthy control, prediabetes, and DM) impairments. We evaluated the cognitive and metabolic functions of the participants with neuropsychological assessments, brain magnetic resonance imaging, and various blood tests, to explore potential relationships with clusterin.
Results: Plasma clusterin levels were higher in participants with AD and metabolic impairment (prediabetes and DM). A two-way ANCOVA revealed no synergistic, but an additive effect of AD and DM on clusterin. Clusterin was negatively correlated with cognitive scores. It was also associated with metabolic status indicated by glycated hemoglobin A1c (HbA1c), the Homeostatic Model Assessment for Insulin Resistance index, and fasting C-peptide. It showed correlations between medial temporal atrophy and periventricular white matter lesions, indicating neurodegeneration and microvascular insufficiency, respectively. Further mediation analysis to understand the triadic relationship between clusterin, AD, and DM revealed that the association between DM and AD was significant when clusterin is considered as a mediator of their relationship.
Conclusions: Clusterin is a promising biomarker of DM as well as of AD. Additionally, our data suggest that clusterin may have a role in linking DM with AD as a potential mediator.
Keywords: Alzheimer disease; biomarker; brain atrophy; clusterin; diabetes mellitus; insulin resistance.
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Comment in
-
The Emerging Role of the Apolipoproteins APOE and APOJ in the Interaction Between Diabetes and Alzheimer Disease.J Clin Endocrinol Metab. 2020 Nov 1;105(11):dgaa570. doi: 10.1210/clinem/dgaa570. J Clin Endocrinol Metab. 2020. PMID: 32895708 No abstract available.
Similar articles
-
Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment.Neuroimage. 2012 Jan 2;59(1):212-7. doi: 10.1016/j.neuroimage.2011.07.056. Epub 2011 Jul 28. Neuroimage. 2012. PMID: 21824521 Free PMC article.
-
Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.J Alzheimers Dis. 2015;46(4):1103-10. doi: 10.3233/JAD-150036. J Alzheimers Dis. 2015. PMID: 26402636
-
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.Arch Gen Psychiatry. 2010 Jul;67(7):739-48. doi: 10.1001/archgenpsychiatry.2010.78. Arch Gen Psychiatry. 2010. PMID: 20603455 Free PMC article.
-
Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential.Curr Aging Sci. 2011 Jul;4(2):118-27. doi: 10.2174/1874609811104020118. Curr Aging Sci. 2011. PMID: 21235496 Review.
-
Diabetes and neurodegeneration in the brain.Handb Clin Neurol. 2014;126:489-511. doi: 10.1016/B978-0-444-53480-4.00035-7. Handb Clin Neurol. 2014. PMID: 25410241 Review.
Cited by
-
Increased GPC4 and clusterin associated with insulin resistance in patients with PCOS.Endocr Connect. 2024 Feb 22;13(3):e230428. doi: 10.1530/EC-23-0428. Print 2024 Mar 1. Endocr Connect. 2024. PMID: 38251963 Free PMC article.
-
Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer's model mice.Transl Psychiatry. 2024 Jan 18;14(1):34. doi: 10.1038/s41398-024-02755-9. Transl Psychiatry. 2024. PMID: 38238285 Free PMC article.
-
Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response.Clin Proteomics. 2023 Sep 21;20(1):38. doi: 10.1186/s12014-023-09429-6. Clin Proteomics. 2023. PMID: 37735622 Free PMC article. Review.
-
Metabolic Profile of Alzheimer's Disease: Is 10-Hydroxy-2-decenoic Acid a Pertinent Metabolic Adjuster?Metabolites. 2023 Aug 18;13(8):954. doi: 10.3390/metabo13080954. Metabolites. 2023. PMID: 37623897 Free PMC article. Review.
-
Monitoring clusterin and fibrillar structures in aging and dementia.Aging Brain. 2023 Jun 6;3:100080. doi: 10.1016/j.nbas.2023.100080. eCollection 2023. Aging Brain. 2023. PMID: 37346145 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous